nitrofen has been researched along with imatinib mesylate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YT; Eklöf, AC; Frenckner, B; Hedin, U; Lengquist, M; Osterholm, C; Ringman Uggla, A; Tran, PK; Tran-Lundmark, K | 1 |
| Burgos, CM; Davey, MG; Flake, AW; Jia, H; Peranteau, WH; Riley, JS | 1 |
2 other study(ies) available for nitrofen and imatinib mesylate
| Article | Year |
|---|---|
Antenatal imatinib treatment reduces pulmonary vascular remodeling in a rat model of congenital diaphragmatic hernia.
Topics: Airway Remodeling; Animals; Apoptosis; Benzamides; Caspase 3; Cell Proliferation; Disease Models, Animal; Female; Hernia, Diaphragmatic; Hernias, Diaphragmatic, Congenital; Imatinib Mesylate; Ki-67 Antigen; Lung; Phenyl Ethers; Piperazines; Platelet-Derived Growth Factor; Pregnancy; Pulmonary Artery; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Platelet-Derived Growth Factor; RNA, Messenger | 2012 |
Lung function and pulmonary artery blood flow following prenatal maternal retinoic acid and imatinib in the nitrofen model of congenital diaphragmatic hernia.
Topics: Animals; Drug Administration Schedule; Female; Hernias, Diaphragmatic, Congenital; Imatinib Mesylate; Lung; Phenyl Ethers; Pregnancy; Prenatal Care; Protein Kinase Inhibitors; Pulmonary Alveoli; Pulmonary Artery; Random Allocation; Rats; Rats, Sprague-Dawley; Treatment Outcome; Tretinoin | 2018 |